180 Life Sciences’ Woody Sets Out Vision For Repurposing Anti-TNF Biologics

CEO Expands On Recent Announcement Of Collaboration With Celltrion

 
• By David Wallace
  
Three Targets Arrows
Three new indications are being targeted by the company • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business